Basis of Presentation (Tables)

6 Months Ended

Jun. 30, 2012

Basis of Presentation [Abstract]

Summary of assets and liabilities measured at fair value on a recurring basis

	June 30, 2012								December 31, 2011
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Fair Value Measurements Using:
Assets
Derivative asset (warrant) (note 7)	$	—	$	401,200	$	—	$	401,200	$	—	$	388,540	$	—	$	388,540
Liabilities
Derivative liabilities (note 7)	$	—	$	5,638,001	$	—	$	5,638,001	$	—	$	279,302	$	—	$	279,302

Reconciliation of beginning and ending balances of assets and liabilities measured at fair value using significant observable inputs

	$		Number of Warrants
Assets:
Warrant asset as of January 1, 2012	$	388,540		2,000,000
Increase in fair value of warrants		12,660		—
Warrant asset as of June 30, 2012	$	401,200		2,000,000
Liabilities:
Warrant liability as of January 1, 2012	$	279,302		3,246,301
Expiration of CDC* warrants		—		(1,000,000	)
Increase in fair value of warrants		5,358,699		—
Warrant liability as of June 30, 2012	$	5,638,001		2,246,301

* Clinical Development Capital, LLC and its successors and/or affiliates (“CDC”), who previously provided financing for the development of the Company’s ONSOLIS^® product. See Note 5.